Product Information

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB is a generic product labeled by American Health Packaging, priced at $0.0969 per EA under NDC 68084075025. Its NADAC has been published 547 times since Apr 13, 2016.

FDA first approved this application on Apr 17, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Triamterene and Hydrochlorothiazide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB

Triamterene and Hydrochlorothiazide
$0.0969per EA
Low Outlier

Strength

25; 37.5 mg/1; mg/1

NDC

68084075025

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA071251

FDA Approved

4/17/1988

TE Code

AB

On Market Since

3/21/2016

Pharmacological Classes

Decreased Renal K+ Excretion
Increased Diuresis
Increased Diuresis
Potassium-sparing Diuretic
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has been published 547 times since Apr 13, 2016, and over the history we have for it it has declined 38.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0969 per EA
All-time high$0.1574 (Apr 13, 2016)
All-time low$0.0721 (Nov 20, 2024)
52-week high$0.0983
52-week low$0.0915
Median price$0.1023
Average price$0.1061
Largest weekly change-29.0% (Nov 20, 2024)
Weeks tracked547
Tracking sinceApr 13, 2016

Price History

1W

0.0%

1M

-1.4%

3M

+0.9%

6M

+0.7%

1Y

+5.9%

3Y

+12.3%

5Y

-14.7%

All

-38.4%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, manufactured by American Health Packaging, is $0.0969 per EA (NDC 68084075025), effective Sep 30, 2026.

How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB changed over time?

Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has declined 38.4%. It has been tracked across 547 weekly CMS publications since Apr 13, 2016.

What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

Since Apr 13, 2016, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has ranged from a low of $0.0721 (Nov 20, 2024) to a high of $0.1574 (Apr 13, 2016), with a median of $0.1023 per EA.

Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, is $0.0963 per EA — about 1% below TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB.

Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB (NDC 68084075025) is labeled by American Health Packaging, and CMS classifies it as a generic product.